Malignant Bone Neoplasm — Trials

Malignant Bone Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

152 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 38
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 31.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 151–152 of 152 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00127387	Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia	terminated	Phase 2 / Phase 3	54	The University of Texas Health Science Center at San AntonioOTHER	1	Jun 26, 2012	clinicaltrials
NCT00423254	Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.	completed	Phase 1	12	Mannkind CorporationINDUSTRY	1	Aug 3, 2010	clinicaltrials